Kim, Hyung-Sun
Kang, Goo-Hwa
Yang, Mi-Jin
Joo, Yun-Jeong
Lee, Dong-Gi
Lee, Han-Seung
Lee, Jong-Seung
Hwang, Jeong Ho https://orcid.org/0000-0002-4763-8373
Article History
Received: 9 August 2023
Revised: 4 December 2023
Accepted: 11 December 2023
First Online: 6 February 2024
Declarations
:
: The authors declare that they have no competing financial interests or personal relationships that may have influenced the work reported in this study.
: This study was conducted in compliance with Good Laboratory Practice (GLP) regulations, the Ministry of Food and Drug Safety Notification No. 2017–71 Test Guidelines for Safety Evaluation of Drugs and Annex 2 Repeated Dose Toxicity Study, and the ICH Harmonized Tripartite Guidelines M3 (R2) Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals. All experimental procedures were approved by the Institutional Animal Care and Use Committee of the Korea Institute of Toxicology (KIT-2112-0092).
: All authors agreed to authorship, read and approved the manuscript, and given consent for publication.